Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Maria Sjölander

Maria Sjölander

Jag undervisar om värdering av läkemedel, främst på farmaciprogrammen, och forskar om användning av läkemedel och effekter av läkemedelsanvändning.

Kontakt

E-post
maria.sjolander@umu.se
Telefon
090-786 72 86

Verksam vid

Anknytning
Universitetslektor vid Institutionen för integrativ medicinsk biologi (IMB)
Plats
hus H, Johan Bures väg 12, Biologihuset Umeå universitet, 901 87 Umeå
Pharmacological Pain Treatment in 2012 and 2017 Among Older People with Major Neurocognitive Disorder
Drugs & Aging
Gustafsson, Maria; Lövheim, Hugo; Sjölander, Maria
Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries
European Journal of Clinical Pharmacology
Kindstedt, Jonas; Sjölander, Maria; Lövheim, Hugo; et al.
Prescription of Lipid-Lowering and Antihypertensive Drugs following Pictorial Information about Subclinical Atherosclerosis: A Secondary Outcome of a Randomized Clinical Trial
JAMA Network Open, American Medical Association 2021, Vol. 4, (8)
Sjölander, Maria; Carlberg, Bo; Norberg, Margareta; et al.
Investigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trial
BMJ Open, BMJ Publishing Group Ltd 2020, Vol. 10, (4)
Kindstedt, Jonas; Svahn, Sofia; Sjölander, Maria; et al.
Prescription of lipid-lowering drugs increases following receipt of a pictorial representation of patients´carotid ultrasound examinations
Research in Social and Administrative Pharmacy, Elsevier 2019, Vol. 15, (12) : E49-E49
Sjölander, Maria; Carlberg, Bo; Norberg, Margareta; et al.
Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among Swedish older patients with dementia or cognitive impairment: an economic evaluation
Research in Social and Administrative Pharmacy, Elsevier 2019, Vol. 5, (3) : 287-291
Sjölander, Maria; Lindholm, Lars; Pfister, Bettina; et al.
Letter to the Editor: Clinically relevant drug-drug interactions among elderly people with dementia
European Journal of Clinical Pharmacology, SPRINGER HEIDELBERG 2019, Vol. 75, (9) : 1321-1322
Sönnerstam, Eva; Sjölander, Maria; Lövheim, Hugo; et al.
Effects of pharmacists' interventions on inappropriate drug use and drug-related readmissions in people with dementia: a secondary analysis of a randomized controlled trial
Pharmacy, Basel: MDPI 2018, Vol. 6, (1)
Gustafsson, Maria; Sjölander, Maria; Pfister, Bettina; et al.
Clinically relevant drug-drug interactions among elderly people with dementia
European Journal of Clinical Pharmacology, Springer Berlin/Heidelberg 2018, Vol. 74, (10) : 1351-1360
Sönnerstam, Eva; Sjölander, Maria; Lövheim, Hugo; et al.
Where there is no pharmacist: doctors' and nurses' expectations on the implementation of clinical pharmacy services in rural Sweden
International Journal of Clinical Pharmacy, SPRINGER 2017, Vol. 39, (1) : 216-216
Gustafsson, Maria; Sjölander, Maria; Gallego, Gisselle
Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial
European Journal of Clinical Pharmacology, Springer 2017, Vol. 7, (73) : 827-835
Gustafsson, Maria; Sjölander, Maria; Pfister, Bettina; et al.
Doctors' and nurses' perceptions of a ward-based pharmacist in rural northern Sweden
International Journal of Clinical Pharmacy, Vol. 39, (4) : 953-959
Sjölander, Maria; Gustafsson, Maria; Gallego, Gisselle
An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list
European Journal of Clinical Pharmacology, Vol. 73, (6) : 735-742
Sönnerstam, Eva; Sjölander, Maria; Gustafsson, Maria
Drug-related hospital admissions among old people with dementia
European Journal of Clinical Pharmacology, Vol. 72, (9) : 1143-1153
Gustafsson, Maria; Sjölander, Maria; Pfister, Bettina; et al.
Inequalities in medication adherence to statin treatment after stroke: A nationwide observational study
European Stroke Journal, Sage Publications 2016, Vol. 1, (2) : 101-107
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Inappropriate Prescription and Renal Function Among Older Patients with Cognitive Impairment
Drugs and aging, Springer 2016, Vol. 33, (12) : 889-899
Sönnerstam, Eva; Sjölander, Maria; Gustafsson, Maria
Reduction in the use of potentially inappropriate drugs among old people living in geriatric care units between 2007 and 2013
European Journal of Clinical Pharmacology, Vol. 71, (4) : 507-515
Gustafsson, Maria; Sandman, Per-Olof; Karlsson, Stig; et al.
Socioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation
Stroke, Vol. 46, (8) : 2220-2225
Sjölander, Maria; Eriksson, Marie; Asplund, Kjell; et al.
Use of secondary preventive drugs after stroke
Umeå University medical dissertations, 1603
Sjölander, Maria
The association between patients' beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey
BMJ Open, Vol. 3, (9)
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Social stratification in the dissemination of statins after stroke in Sweden
European Journal of Clinical Pharmacology, Heidelberg: Springer Berlin/Heidelberg 2013, Vol. 69, (5) : 1173-1180
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study
Pharmacoepidemiology and Drug Safety, San Francisco: John Wiley & Sons 2012, Vol. 21, (9) : 911-919
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Few sex differences in use of drugs for secondary prevention after stroke: a nationwide observational study
Abstracts 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Hyatt Regency Chicago: Chicago, Illinois, USA August 14–17, 2011, Wiley 2011 : S110-S110
Sjölander, Maria; Eriksson, Marie; Glader, Eva-Lotta
Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke.
Stroke, American Heart Association 2010, Vol. 41, (2) : 397-401
Glader, Eva-Lotta; Sjölander, Maria; Eriksson, Marie; et al.
Visa publikationer i DiVA

Forskningsprojekt

29 april 2013 till 31 december 2027
VIPVIZA